These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9301273)

  • 21. Inhibitors of protein tyrosine phosphorylation reduce the proliferation of two human glioma cell lines.
    Oude Weernink PA; Verheul E; Kerkhof E; van Veelen CW; Rijksen G
    Neurosurgery; 1996 Jan; 38(1):108-13; discussion 113-4. PubMed ID: 8747958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of tyrosine kinase activity abolishes anabolic and mitogenic effects of prolactin and growth hormone in Nb2 cells.
    Carey GB; Liberti JP
    Biochem Mol Biol Int; 1993 Nov; 31(4):635-42. PubMed ID: 8298493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein tyrosine phosphorylation and calcium signaling in thyroid FRTL-5 cells.
    Törnquist K; Dugué B; Ekokoski E
    J Cell Physiol; 1998 May; 175(2):211-9. PubMed ID: 9525480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The tyrosine kinase inhibitors, genistein and methyl 2,5-dihydroxycinnamate, inhibit the release of (3H)arachidonate from human platelets stimulated by thrombin or collagen.
    Hargreaves PG; Licking EF; Sargeant P; Sage SO; Barnes MJ; Farndale RW
    Thromb Haemost; 1994 Oct; 72(4):634-42. PubMed ID: 7878644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inhibitors of protein-tyrosine kinases: pharmacological perspectives?].
    Jacquemin-Sablon A; Agbotounou WK; Pierre J
    Pathol Biol (Paris); 1995 May; 43(5):389-94. PubMed ID: 8532375
    [No Abstract]   [Full Text] [Related]  

  • 26. Genistein, a tyrosine kinase inhibitor, reduces EGF-induced EGF receptor internalization and degradation in human hepatoma HepG2 cells.
    Yang EB; Wang DF; Mack P; Cheng LY
    Biochem Biophys Res Commun; 1996 Jul; 224(2):309-17. PubMed ID: 8702388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tyrosine kinase inhibitors inhibit multiple steps of the cell cycle of vascular smooth muscle cells.
    Shimokado K; Umezawa K; Ogata J
    Exp Cell Res; 1995 Oct; 220(2):266-73. PubMed ID: 7556433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute neurite retraction elicited by diverse agents is prevented by genistein, a tyrosine kinase inhibitor.
    Smalheiser NR
    J Neurochem; 1993 Jul; 61(1):340-3. PubMed ID: 8515281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genistein activates CFTR Cl- channels via a tyrosine kinase- and protein phosphatase-independent mechanism.
    French PJ; Bijman J; Bot AG; Boomaars WE; Scholte BJ; de Jonge HR
    Am J Physiol; 1997 Aug; 273(2 Pt 1):C747-53. PubMed ID: 9277373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effects of genistein on ATP-sensitive K+ channels in rabbit portal vein smooth muscle.
    Ogata R; Kitamura K; Ito Y; Nakano H
    Br J Pharmacol; 1997 Dec; 122(7):1395-404. PubMed ID: 9421287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of CFTR chloride channels by calyculin A and genistein.
    Yang IC; Cheng TH; Wang F; Price EM; Hwang TC
    Am J Physiol; 1997 Jan; 272(1 Pt 1):C142-55. PubMed ID: 9038820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombin receptor activation causes rapid neural cell rounding and neurite retraction independent of classic second messengers.
    Jalink K; Moolenaar WH
    J Cell Biol; 1992 Jul; 118(2):411-9. PubMed ID: 1321160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of liver canalicular transport processes by the tyrosine-kinase inhibitor genistein: implications of genistein metabolism in the rat.
    Jäger W; Winter O; Halper B; Salamon A; Sartori M; Gajdzik L; Hamilton G; Theyer G; Graf J; Thalhammer T
    Hepatology; 1997 Dec; 26(6):1467-76. PubMed ID: 9397986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of carnitine binding to plasma membranes by an ATP-dependent mechanism.
    Gustafson B; Ransnäs LA
    Biochem Biophys Res Commun; 1997 Feb; 231(2):249-53. PubMed ID: 9070258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of genistein on both basal and glucagon-induced levels of cAMP in rat hepatocytes.
    Keppens S
    Biochem Pharmacol; 1995 Oct; 50(8):1303-4. PubMed ID: 7488248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of protein tyrosine phosphorylation in endothelial cells: relationship to antiproliferative action of genistein.
    Koroma BM; de Juan E
    Biochem Soc Trans; 1997 Feb; 25(1):35-40. PubMed ID: 9056839
    [No Abstract]   [Full Text] [Related]  

  • 37. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene.
    Peterson G; Barnes S
    Biochem Biophys Res Commun; 1991 Aug; 179(1):661-7. PubMed ID: 1883387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isoflavonoids, genistein, psi-tectorigenin, and orobol, increase cytoplasmic free calcium in isolated rat hepatocytes.
    Tomonaga T; Mine T; Kojima I; Taira M; Hayashi H; Isono K
    Biochem Biophys Res Commun; 1992 Jan; 182(2):894-9. PubMed ID: 1734888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The protein tyrosine kinase inhibitor herbimycin A, but not genistein, specifically inhibits signal transduction by the T cell antigen receptor.
    Graber M; June CH; Samelson LE; Weiss A
    Int Immunol; 1992 Nov; 4(11):1201-10. PubMed ID: 1472473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Noncatalytic inhibition of cyclic nucleotide-gated channels by tyrosine kinase induced by genistein.
    Molokanova E; Savchenko A; Kramer RH
    J Gen Physiol; 1999 Jan; 113(1):45-56. PubMed ID: 9874687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.